Your browser doesn't support javascript.
loading
Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia.
Maeda, Takuya; Hiura, Azusa; Uehara, Jiro; Toyoshima, Rino; Nakagawa, Tomoe; Yoshino, Koji.
Afiliación
  • Maeda T; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Hiura A; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Toyoshima R; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Nakagawa T; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Yoshino K; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Eur J Dermatol ; 31(5): 662-664, 2021 Oct 01.
Article en En | MEDLINE | ID: mdl-34642136

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Nivolumab / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Dermatol Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Protocolos de Quimioterapia Combinada Antineoplásica / Ipilimumab / Nivolumab / Melanoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Dermatol Asunto de la revista: DERMATOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Francia